hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 09:29:40 - browse：95736

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Listen: Biogen's potential pivot, & Illumina's next chapter

WSS

A rare thyroid diagnosis led to unexpected, all

Fatty liver disease was alleviated by Lilly’s ‘triple

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

leisure time

hotspot

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Dexcom's push to bring CGM to type 2 diabetes patients

In Memoriam: Notable people who died in 2023

Humana sues Biden admin over Medicare Advantage audit rule

Psychedelics group wrestles with new pharma identity

The wait for US passports is creating travel purgatory and snarling summer plans

New air purifier tech could be key to improving indoor air quality

Amazon on where the company's health care bets are headed next

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

AstraZeneca chief proposes a novel edit to the drug pricing bill

Wikipedia

AstraZeneca chief proposes a novel edit to the drug pricing bill

How to protect patients from sexual assault

Stem cell treatment guidelines are released by FDA

Advances in CAR

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Ethical issues complicate the benefits of medical crowdfunding

leisure time

knowledge

focus

leisure time